CARE FAKEEH

Dr. Soliman Abdul Kader Fakeeh Hospital Co.

4017StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	8.58B	7.78B	7.84B	9.52B	9.36B
Market Cap Growth	-9.2%	-31.8%	-49.1%	-29.2%	-33.1%
Enterprise Value	9.85B	8.93B	8.92B	10.71B	10.37B
Last Close Price	37.30	33.84	34.10	41.40	40.68
Valuation Multiples
Forward PE (Next 12M Est.)	28.21	21.37	22.08	29.05	27.05
PE Ratio	33.46	30.36	27.03	31.77	29.09
PEG Ratio	2.33	1.77	1.49	1.96	1.83
PS Ratio	2.76	2.50	2.54	3.14	3.15
PB Ratio	2.37	2.15	2.19	2.71	2.73
P/TBV Ratio	3.22	2.92	2.99	3.71	3.75
P/FCF Ratio	155.17	—	-1,032.79	-53.33	—
P/OCF Ratio	23.01	20.88	17.28	18.49	—
EV/Sales Ratio	3.16	2.87	2.89	3.53	3.49
EV/EBITDA Ratio	21.28	22.39	21.05	25.47	23.37
EV/EBIT Ratio	35.74	32.40	28.95	35.13	30.93
EV/FCF Ratio	178.16	—	-1,174.13	-60.00	—
Leverage & Capital
Debt / Equity Ratio	0.35	0.35	0.33	0.30	0.31
Debt / EBITDA Ratio	2.76	3.35	2.52	2.14	2.10
Debt / FCF Ratio	23.12	—	-154.91	-5.91	—
Net Debt / Equity Ratio	0.24	0.24	0.21	0.19	0.23
Net Debt / EBITDA Ratio	2.15	2.15	1.74	1.58	1.80
Net Debt / FCF Ratio	15.48	15.48	-97.08	-3.71	-3.02
Efficiency & Liquidity
Asset Turnover	0.49	0.56	0.55	0.59	0.53
Inventory Turnover	12.30	11.62	12.52	11.65	12.67
Quick Ratio	1.32	1.32	1.33	1.41	1.43
Current Ratio	1.65	1.65	1.63	1.76	1.73
Returns & Yields
Return on Equity (ROE)	+2.9%	+6.3%	+6.6%	+8.0%	+8.0%
Return on Assets (ROA)	+1.9%	+3.3%	+3.3%	+3.7%	+3.6%
Return on Invested Capital (ROIC)	+0.8%	+1.5%	+1.6%	+1.7%	+1.8%
Return on Capital Employed (ROCE)	+5.7%	+5.7%	+6.5%	+6.6%	+7.5%
Earnings Yield	+3.0%	+3.3%	+3.7%	+3.1%	+3.4%
FCF Yield	+0.6%	+0.7%	-0.1%	-1.9%	-2.8%
Dividend Yield	+0.9%	—	+1.0%	—	—
Payout Ratio	+26.9%	—	—	+96.3%	—
Buyback Yield / Dilution	-2.4%	—	0.0%	-8.6%	-10.5%
Total Shareholder Return	-1.5%	—	+0.9%	-8.6%	-10.5%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	8.58B	7.78B	7.84B	9.52B	9.36B
Market Cap Growth	-9.2%	-31.8%	-49.1%	-29.2%	-33.1%
Enterprise Value	9.85B	8.93B	8.92B	10.71B	10.37B
Last Close Price	37.30	33.84	34.10	41.40	40.68
Valuation Multiples
Forward PE (Next 12M Est.)	28.21	21.37	22.08	29.05	27.05
PE Ratio	33.46	30.36	27.03	31.77	29.09
PEG Ratio	2.33	1.77	1.49	1.96	1.83
PS Ratio	2.76	2.50	2.54	3.14	3.15
PB Ratio	2.37	2.15	2.19	2.71	2.73
P/TBV Ratio	3.22	2.92	2.99	3.71	3.75
P/FCF Ratio	155.17	—	-1,032.79	-53.33	—
P/OCF Ratio	23.01	20.88	17.28	18.49	—
EV/Sales Ratio	3.16	2.87	2.89	3.53	3.49
EV/EBITDA Ratio	21.28	22.39	21.05	25.47	23.37
EV/EBIT Ratio	35.74	32.40	28.95	35.13	30.93
EV/FCF Ratio	178.16	—	-1,174.13	-60.00	—
Leverage & Capital
Debt / Equity Ratio	0.35	0.35	0.33	0.30	0.31
Debt / EBITDA Ratio	2.76	3.35	2.52	2.14	2.10
Debt / FCF Ratio	23.12	—	-154.91	-5.91	—
Net Debt / Equity Ratio	0.24	0.24	0.21	0.19	0.23
Net Debt / EBITDA Ratio	2.15	2.15	1.74	1.58	1.80
Net Debt / FCF Ratio	15.48	15.48	-97.08	-3.71	-3.02
Efficiency & Liquidity
Asset Turnover	0.49	0.56	0.55	0.59	0.53
Inventory Turnover	12.30	11.62	12.52	11.65	12.67
Quick Ratio	1.32	1.32	1.33	1.41	1.43
Current Ratio	1.65	1.65	1.63	1.76	1.73
Returns & Yields
Return on Equity (ROE)	+2.9%	+6.3%	+6.6%	+8.0%	+8.0%
Return on Assets (ROA)	+1.9%	+3.3%	+3.3%	+3.7%	+3.6%
Return on Invested Capital (ROIC)	+0.8%	+1.5%	+1.6%	+1.7%	+1.8%
Return on Capital Employed (ROCE)	+5.7%	+5.7%	+6.5%	+6.6%	+7.5%
Earnings Yield	+3.0%	+3.3%	+3.7%	+3.1%	+3.4%
FCF Yield	+0.6%	+0.7%	-0.1%	-1.9%	-2.8%
Dividend Yield	+0.9%	—	+1.0%	—	—
Payout Ratio	+26.9%	—	—	+96.3%	—
Buyback Yield / Dilution	-2.4%	—	0.0%	-8.6%	-10.5%
Total Shareholder Return	-1.5%	—	+0.9%	-8.6%	-10.5%